BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
Holders of 5% or more of BTAIQ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioXcel Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 13G/A | 8.40%1.84M shares | +3.20 ppfrom 5.20% | Oct 1, 20252 filings | Feb 9, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on BioXcel Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 202612:10 PM ET | Qatar Investment Authority | 13G/A | 0.60%156.1K shares | −4.60 ppfrom 5.20%Below 5% | Dec 31, 2025 | SEC |
| Feb 9, 20264:13 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 8.40%1.84M shares | +3.20 ppfrom 5.20% | Dec 31, 2025 | SEC |
| Oct 1, 20254:15 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.20%1.03M shares | New | Sep 29, 2025 | SEC |
| May 15, 20254:15 PM ET | Oaktree Capital Group Holdings GP, LLCand 3 others | 13G/A | 2.73%170.2K shares | −2.47 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20253:33 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%288.1K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:27 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%5.00M shares | New | Dec 31, 2024 | SEC |
| Dec 18, 20248:19 PM ET | Oaktree Capital Group Holdings GP, LLCand 3 others | 13G | 5.20%2.72M shares | New | Nov 25, 2024 | SEC |
| Dec 18, 20245:20 PM ET | Qatar Investment Authority | 13G | 5.20%2.72M shares | New | Nov 25, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BioXcel Therapeutics, Inc. shares.
No Form 144 notices for BioXcel Therapeutics, Inc. are on file.